Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-72,392
Closed -$4.38M 795
2025
Q1
$4.38M Buy
72,392
+68,973
+2,017% +$4.81M 0.08% 115
2024
Q4
$236K Buy
3,419
+110
+3% +$7.84K ﹤0.01% 505
2024
Q3
$219K Buy
+3,309
New +$211K 0.01% 458
2024
Q2
Sell
-4,140
Closed -$236K 675
2024
Q1
$236K Sell
4,140
-2,332
-36% -$140K 0.01% 365
2023
Q4
$406K Buy
+6,472
New +$366K 0.02% 338

Other funds holding INCY

Marex Group's INCY Position: Q2 2025 in Review

Marex Group sold out of Incyte (INCY) in Q2 2025, closing a stake of 72,392 shares — an estimated $4.38M sold.

Marex Group first reported a position in INCY in Q4 2023 and held it in 5 quarters. The position peaked at $4.38M in Q1 2025. 657 funds tracked by Wall St. Rank hold INCY as of Q2 2025.

  • Marex Group reported no remaining Incyte position as of Q2 2025 after selling out during the quarter.
  • Marex Group sold 72,392 Incyte shares in Q2 2025, an estimated $4.38M.
  • Marex Group first reported a position in Incyte in Q4 2023 and held it in 5 quarters.
  • Marex Group's Incyte position peaked at $4.38M in Q1 2025.
  • 657 funds tracked by Wall St. Rank held Incyte as of Q2 2025.

Based on Marex Group's 13F filing for Q2 2025, filed 19 Aug 2025.